Literature DB >> 21273088

The role of Tc-99m-2-Methoxy-Isobutyl-Isonitrile Single Photon Emission Computed Tomography in visualizing anterior mediastinal tumor and differentiating histologic type of thymoma.

Alfonso Fiorelli1, Giovanni Vicidomini, Paolo Laperuta, Pierfrancesco Rambaldi, Luigi Mansi, Antonio Rotondo, Mario Santini.   

Abstract

OBJECTIVE: To evaluate the usefulness of (99m)Tc-2-Methoxy-Isobutyl-Isonitrile Single Photon Emission Computed Tomography (MIBI-SPECT) for assessing anterior mediastinal mass, and distinguishing the grade of malignancy of thymic epithelial tumors to offer guidance for decision making.
METHODS: From January 2006 to November 2009, 31 consecutive patients with an anterior mediastinal mass at CT were enrolled. All patients underwent (99m)Tc-MIBI-SPECT before invasive diagnostic procedures and/or surgical resection. The uptake of the mediastinal tumor (T) was compared with the normal tissue (N) and the T/N ratio was calculated to define the metabolic activity of the lesions. Patients were divided into six groups according histologic patterns, which were then correlated to the T/N value: benign tumor (BT), lymphoma (LYM), other malignant tumor (OMT), and low-risk thymoma (LRT) including types A, AB, and B1, high-risk thymoma (HRT) including types B2 and B3, and thymic carcinoma (TC).
RESULTS: There were five BT, eight LRT (four = A, two = AB, and two = B1), four HRT (three = B2 and one = B3), four thymic carcinoma, six LYM and four OMT. The T/N value of BT, LRT, HRT, CT, LYM, and OMT was 1.3 ± 0.3, 1.3 ± 0.2, 1.8 ± 0.3, 2.7 ± 0.5, 2.8 ± 0.1, and 2.9 ± 0.2, respectively. The T/N ratio of BT and of LRT was significantly lower than that of HRT, of CT, of LYM, and of OMT (p < 0.05), while there is no significant difference of MIBI uptake between BT and LRT. MIBI uptake in HRT was significantly lower than that in TC, LYM, and OMT (p < 0.05), whereas no significant difference was found between the different types of malignant lesions (TC, LYM, and OMT). Regarding thymoma, the degree of MIBI accumulation significantly increased as the World Health Organization (WHO) classification shifted from type A to type B and to TC. Yet, the T/N value of stages I and II was significantly lower than that of stages III and IV. The size of the lesion and the presence of myasthenia were not correlated with MIBI uptake.
CONCLUSION: (99m)Tc-MIBI-SPECT seems to be useful in the evaluation of malignancy in anterior mediastinal mass, and is significantly correlated with the WHO classification and the Masaoka stage. Thus, this technique may add further information to morphological studies for decision making.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273088     DOI: 10.1016/j.ejcts.2010.10.005

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Precision medicine in myasthenia graves: begin from the data precision.

Authors:  Hai-Feng Li; Yu Hong; Yanchen Xie; Hong-Jun Hao; Ren-Cheng Sun
Journal:  Ann Transl Med       Date:  2016-03

2.  Application values of 99mTc-methoxyisobutylisonitrile imaging for differentiating benign and malignant thymic masses.

Authors:  Chenghui Lu; Xufu Wang; Bin Liu; Xinfeng Liu; Guoming Wang; Qin Zhang
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

Review 3.  Clinical diagnosis of malignant pleural mesothelioma.

Authors:  Andrea Bianco; Tullio Valente; Maria Luisa De Rimini; Giacomo Sica; Alfonso Fiorelli
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  In the era of ultrasound technology, could conventional trans-bronchial needle aspiration still play a role in lung cancer mediastinal staging?

Authors:  Alfonso Fiorelli; Carlo Santoriello; Davide Di Natale; Roberto Cascone; Valentina Musella; Rossella Mastromarino; Nicola Serra; Giovanni Vicidomini; Mario Polverino; Mario Santini
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

5.  99mTc MIBI THYMIC SCINTIGRAPHY IN DIAGNOSIS AND THERAPEUTIC DECISION MAKING: WHAT IS BEHIND THE IMAGE?

Authors:  C Ştefănescu; L Ionescu; R Dănilă; D Butcovan; R Tibu; S Bilha; D Timofte; C Vulpoi
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

6.  Detection of Thymoma on 99mTc MIBI Scintigraphy: Revisiting the Past.

Authors:  Girish Kumar Parida; Shambo Guha Roy; Anshul Sharma; Chetan D Patel
Journal:  Indian J Nucl Med       Date:  2017 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.